Reboxetine a pharmacologically potent selective and specific norepinephrine reuptake inhibitor Post published:May 30, 2000 Post category:Central Nervous System / Publications Reboxetine a pharmacologically potent selective and specific norepinephrine reuptake inhibitor. PORSOLT_Reboxetine-a-pharmacologically-potent-selective-and-specific-norepinephrine-reuptake-inhibitorDownload Read more articles Previous PostEvaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition Next PostAnimal models of depression utility for transgenic research You Might Also Like Animal models of depression utility for transgenic research December 8, 2000 PORSOLT continues to expand its dermatology models in the field of Atopic Dermatitis, a form of Eczema. April 13, 2022 Preclinical profiling and safety studies of ABT-769 – A compound with potential for broad-spectrum antiepileptic activity September 11, 2005
PORSOLT continues to expand its dermatology models in the field of Atopic Dermatitis, a form of Eczema. April 13, 2022
Preclinical profiling and safety studies of ABT-769 – A compound with potential for broad-spectrum antiepileptic activity September 11, 2005
